Furth C - Search Results

1

Simultaneous [18F]fluoride and gadobutrol enhanced coronary positron emission tomography/magnetic resonance imaging for in vivo plaque characterization.

Wurster TH, Landmesser U, Abdelwahed YS, Skurk C, Morguet A, Leistner DM, Fröhlich G, Haghikia A, Engel LC, Schuster A, Noutsias M, Schulze D, Hamm B, Furth C, Brenner W, Botnar RM, Bigalke B, Makowski MR. Wurster TH, et al. Among authors: furth c. Eur Heart J Cardiovasc Imaging. 2022 Sep 10;23(10):1391-1398. doi: 10.1093/ehjci/jeab276. Eur Heart J Cardiovasc Imaging. 2022. PMID: 35015852

2

Use of positron emission tomography for staging, preoperative response assessment and posttherapeutic evaluation in children with Wilms tumour.

Misch D, Steffen IG, Schönberger S, Voelker T, Furth C, Stöver B, Hautzel H, Henze G, Amthauer H, Denecke T. Misch D, et al. Among authors: furth c. Eur J Nucl Med Mol Imaging. 2008 Sep;35(9):1642-50. doi: 10.1007/s00259-008-0819-9. Epub 2008 May 29. Eur J Nucl Med Mol Imaging. 2008. PMID: 18509634

3

Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.

Denecke T, Hundsdörfer P, Misch D, Steffen IG, Schönberger S, Furth C, Plotkin M, Ruf J, Hautzel H, Stöver B, Kluge R, Bierbach U, Otto S, Beck JF, Franzius C, Henze G, Amthauer H. Denecke T, et al. Among authors: furth c. Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1842-53. doi: 10.1007/s00259-010-1484-3. Epub 2010 May 27. Eur J Nucl Med Mol Imaging. 2010. PMID: 20505933 Clinical Trial.

4

Time course of contrast enhancement by micro-CT with dedicated contrast agents in normal mice and mice with hepatocellular carcinoma: comparison of one iodinated and two nanoparticle-based agents.

Rothe JH, Rudolph I, Rohwer N, Kupitz D, Gregor-Mamoudou B, Derlin T, Furth C, Amthauer H, Brenner W, Buchert R, Cramer T, Apostolova I. Rothe JH, et al. Among authors: furth c. Acad Radiol. 2015 Feb;22(2):169-78. doi: 10.1016/j.acra.2014.07.022. Epub 2014 Oct 1. Acad Radiol. 2015. PMID: 25282584

5

Individualized risk assessment in neuroblastoma: does the tumoral metabolic activity on ¹²³I-MIBG SPECT predict the outcome?

Rogasch JMM, Hundsdoerfer P, Furth C, Wedel F, Hofheinz F, Krüger PC, Lode H, Brenner W, Eggert A, Amthauer H, Schatka I. Rogasch JMM, et al. Among authors: furth c. Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2203-2212. doi: 10.1007/s00259-017-3786-1. Epub 2017 Aug 14. Eur J Nucl Med Mol Imaging. 2017. PMID: 28808732

6

Increased evidence for the prognostic value of FDG uptake on late-treatment PET in non-tumour-affected oesophagus in irradiated patients with oesophageal carcinoma.

Li Y, Hofheinz F, Furth C, Lili C, Hua W, Ghadjar P, Zschaeck S. Li Y, et al. Among authors: furth c. Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1752-1761. doi: 10.1007/s00259-018-3996-1. Epub 2018 Apr 21. Eur J Nucl Med Mol Imaging. 2018. PMID: 29679113

7

⁶⁸ Ga-PSMA-PET/CT for the evaluation of pulmonary metastases and opacities in patients with prostate cancer.

Damjanovic J, Janssen JC, Furth C, Diederichs G, Walter T, Amthauer H, Makowski MR. Damjanovic J, et al. Among authors: furth c. Cancer Imaging. 2018 May 16;18(1):20. doi: 10.1186/s40644-018-0154-8. Cancer Imaging. 2018. PMID: 29769114 Free PMC article.

8

Ga-68-PSMA PET/CT in treatment-naïve patients with prostate cancer: Which clinical parameters and risk stratification systems best predict PSMA-positive metastases?

Rogasch JM, Cash H, Zschaeck S, Elezkurtaj S, Brenner W, Hamm B, Makowski M, Amthauer H, Furth C, Baur ADJ. Rogasch JM, et al. Among authors: furth c. Prostate. 2018 Jul 5. doi: 10.1002/pros.23685. Online ahead of print. Prostate. 2018. PMID: 29978529

9

Validation of Independent Prognostic Value of Asphericity of ¹⁸F-Fluorodeoxyglucose Uptake in Non-Small-Cell Lung Cancer Patients Undergoing Treatment With Curative Intent.

Rogasch JMM, Furth C, Chibolela C, Hofheinz F, Ochsenreither S, Rückert JC, Neudecker J, Böhmer D, von Laffert M, Amthauer H, Frost N. Rogasch JMM, et al. Among authors: furth c. Clin Lung Cancer. 2020 May;21(3):264-272.e6. doi: 10.1016/j.cllc.2019.10.001. Epub 2019 Oct 15. Clin Lung Cancer. 2020. PMID: 31839531

10

Prostate Cancer Nodal Staging: Using Deep Learning to Predict ⁶⁸Ga-PSMA-Positivity from CT Imaging Alone.

Hartenstein A, Lübbe F, Baur ADJ, Rudolph MM, Furth C, Brenner W, Amthauer H, Hamm B, Makowski M, Penzkofer T. Hartenstein A, et al. Among authors: furth c. Sci Rep. 2020 Feb 25;10(1):3398. doi: 10.1038/s41598-020-60311-z. Sci Rep. 2020. PMID: 32099001 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page